Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer

Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer. Strahlentherapie und Onkologie. April 2018, 194 (4):311-317. Purpose: The purpose of the study was to report the outcomes and late toxicities in patients younger than 60 years of age with long-term follow-up treated with low dose rate (LDR) brachytherapy for localized prostate cancer.